Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Clinical trial NCT05481645 · TERMINATED
Trial details
- NCT number
- NCT05481645
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2024-02-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.